CKD Bio Corp. Statistics
Want to see KR:063160 full AI Analyst Report?
CKD Bio Corp. (063160) Stock Statistics & Valuation Metrics
Total Valuation
CKD Bio Corp. has a market cap or net worth of KRW 63.31B. The enterprise value is KRW 219.49B.
- Market Cap
- KRW 63.31B
- Enterprise Value
- KRW 219.49B
Share Statistics
CKD Bio Corp. has 5,485,962 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 5,485,962
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
CKD Bio Corp.’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is 1.28%.
- Return on Equity (ROE)
- -0.02
- Return on Assets (ROA)
- -0.01
- Return on Invested Capital (ROIC)
- 1.28%
- Return on Capital Employed (ROCE)
- 0.02
- Revenue Per Employee
- 300.32M
- Profits Per Employee
- -5.42M
- Employee Count
- 533
- Asset Turnover
- 0.53
- Inventory Turnover
- 1.38
Valuation Ratios
The current PE Ratio of CKD Bio Corp. is -3.28. CKD Bio Corp.’s PEG ratio is 0.03.
- PE Ratio
- -3.28
- PS Ratio
- 0.41
- PB Ratio
- 0.52
- Price to FCF
- -6.41
- Price to Operating Cash Flow
- 62.10
- PEG Ratio
- 0.03
Income Statement
In the last 12 months, CKD Bio Corp. had revenue of 160.07B and earned -2.89B in profits. Earnings per share was -526.16.
- Revenue
- 160.07B
- Gross Profit
- 26.10B
- Operating Income
- 3.61B
- Pretax Income
- -2.97B
- Net Income
- -2.89B
- EBITDA
- 19.26B
- Earnings Per Share (EPS)
- -526.16
Cash Flow
In the last 12 months, operating cash flow was 1.01B and capital expenditures -10.75B, giving a free cash flow of -9.74B billion.
- Operating Cash Flow
- 1.01B
- Free Cash Flow
- -9.74B
- Free Cash Flow per Share
- -1776.03
Dividends & Yields
CKD Bio Corp. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -15.26%
- Earnings Yield
- -29.82%
Stock Price Statistics
- Beta
- 0.20
- 52-Week Price Change
- -43.90%
- 50-Day Moving Average
- 12965.60
- 200-Day Moving Average
- 16131.55
- Relative Strength Index (RSI)
- 38.14
- Average Volume (3m)
- 18.08K
Important Dates
CKD Bio Corp. upcoming earnings date is ―, TBA (Confirmed).
- Last Earnings Date
- Aug 14, 2026
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
CKD Bio Corp. as a current ratio of 0.90, with Debt / Equity ratio of 114.11%
- Current Ratio
- 0.90
- Quick Ratio
- 0.26
- Debt to Market Cap
- 1.28
- Net Debt to EBITDA
- 7.45
- Interest Coverage Ratio
- 0.64
Taxes
In the past 12 months, CKD Bio Corp. has paid -78.27M in taxes.
- Income Tax
- -78.27M
- Effective Tax Rate
- 0.03
Enterprise Valuation
CKD Bio Corp. EV to EBITDA ratio is -342.94, with an EV/FCF ratio of -21.68.
- EV to Sales
- 1.38
- EV to EBITDA
- -342.94
- EV to Free Cash Flow
- -21.68
- EV to Operating Cash Flow
- 209.96
Balance Sheet
CKD Bio Corp. has KRW 587.63M in cash and marketable securities with KRW 147.94B in debt, giving a net cash position of -KRW 147.35B billion.
- Cash & Marketable Securities
- KRW 587.63M
- Total Debt
- KRW 147.94B
- Net Cash
- -KRW 147.35B
- Net Cash Per Share
- -KRW 26.86K
- Tangible Book Value Per Share
- KRW 20.88K
Margins
Gross margin is 5.05%, with operating margin of -8.21%, and net profit margin of -12.42%.
- Gross Margin
- 5.05%
- Operating Margin
- -8.21%
- Pretax Margin
- -12.64%
- Net Profit Margin
- -12.42%
- EBITDA Margin
- -0.40%
- EBIT Margin
- -8.21%
Analyst Forecast
The average price target for CKD Bio Corp. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 2.72%
- EPS Growth Forecast
- -3186.88%
Scores
- Smart Score
- ―
- AI Score
- 42
